SCHEMBL7304817

SCHEMBL7304817

CCOc1ccc(S(=O)(=O)N2CCN(C)CC2)cc1-c1c(C(N)=O)c(-c2ccccc2)nn1CC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 14/20 0.56
CA12 O43570 3/20 0.47
CA9 Q16790 3/20 0.47
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
PDE1A P54750 3/20 0.45
PDE1B Q01064 3/20 0.45
PDE1C Q14123 3/20 0.45
PDE4B Q07343 2/20 0.45
PDE2A O00408 1/20 0.45
ABCC4 O15439 1/20 0.45
ABCC5 O15440 1/20 0.45
PDE6D O43924 1/20 0.45
PDE8A O60658 1/20 0.45
PDE9A O76083 1/20 0.45
ABCB11 O95342 1/20 0.45
CYP3A4 P08684 1/20 0.45
HTR1A P08908 1/20 0.45
PDE6A P16499 1/20 0.45
PDE6G P18545 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6197854 0.83 KMT2A (0.55) PDE5ACA12CA9MEN1KMT2A
SCHEMBL7307870 0.81 PDE5A (0.59) PDE5ACA12CA9PDE1APDE1B
SCHEMBL7310252 0.80 PDE5A (0.50) PDE5ACA12CA9MEN1KMT2A
SCHEMBL6197233 0.76 PDE5A (0.72) PDE5APDE1APDE1BPDE1CPDE4B
SCHEMBL5875796 0.73 MEN1 (0.60) MEN1KMT2APOLB
SCHEMBL2568411 0.72 PDE5A (1.00) PDE5APDE1APDE1BPDE1CPDE4B
SCHEMBL6199853 0.70 PDE5A (0.67) PDE5APDE1APDE1BPDE1CPDE6D
SCHEMBL4551788 0.70 POLB (0.60) PDE5AMEN1KMT2APOLB
SCHEMBL6995161 0.70 PDE5A (0.61) PDE5APDE1APDE1BPDE1CPDE4B
SCHEMBL6199066 0.69 KMT2A (0.58) PDE5AKMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6407114-B1 BENIGN PROSTATIC HYPERPLASIA, CARDIOVASCULAR, GASTROINTESTINAL AND RESPIRATORY DISORDER TREATMENT; ANTIASTHMATIC, ANTIALLERGEN, AND ANTIDIABETIC AGENTS PFIZER INC. 2002-06-18 US disclosed
EP-0995751-A2 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction PFIZER INC. (US) 2000-04-26 EP disclosed